• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    State Street SPDR S&P Biotech ETF (NY:XBI)

    132.50 +2.08 (+1.59%)
    Streaming Delayed Price Updated: 10:14 AM EDT, May 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,563,679
    Open 129.99
    Bid (Size) 132.52 (100)
    Ask (Size) 132.54 (400)
    Prev. Close 130.42
    Today's Range 129.80 - 133.28
    52wk Range 75.68 - 139.19
    Shares Outstanding 541,500
    Dividend Yield 1.23%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Small Caps Under Siege: Russell 2000 Enters Correction as Yields Surge
    The small-cap segment of the U.S. stock market has officially entered correction territory, marking a stark reversal for a sector that many analysts expected to lead the "Great Rotation" of 2026. On... 
    Via MarketMinute
    Topics Bonds ETFs Economy
    News headline image
    DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
    iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but... 
    Via The Motley Fool
    Topics Derivatives ETFs Regulatory Compliance

    Performance

    YTD
    +9.0%
    +9.0%
    1 Month
    +2.7%
    +2.7%
    3 Month
    +4.0%
    +4.0%
    6 Month
    +20.6%
    +20.6%
    1 Year
    +58.7%
    +58.7%

    More News

    Read More
    News headline image
    IBRX Stock Rises Overnight: Retail Bets Anktiva’s NCCN 'Recommended' Tag Will Drive Prescriptions And Insurance Wins ↗
    Via Stocktwits
    Topics ETFs
    News headline image
    The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
    Via Finterra
    Topics ETFs Intellectual Property
    News headline image
    Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest? ↗
    Via Stocktwits
    Topics ETFs
    News headline image
    QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit ↗
    Via Stocktwits
    News headline image
    QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗
    Via Stocktwits
    Topics Initial Public Offering
    News headline image
    QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗
    Via Stocktwits
    News headline image
    IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data ↗
    Via Stocktwits
    News headline image
    ALT Stock Drops On Wider-Than-Expected Q4 Loss: Retail Voices Hopes For Deal To Alleviate Cash Concerns ↗
    Via Stocktwits
    News headline image
    Why Did CRMD Stock Tumble Over 11% Today? ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    DAWN Shares Rally On Buyout Speculation But Retail Warns A Deal Might Not Materialise ↗
    Via Stocktwits
    Topics Economy
    News headline image
    IBRX Stock Drops On Investor Concerns Over Immunotherapy Launch In Saudi Arabia Amid Middle East Tensions But Analyst Sees 20% Upside ↗
    Via Stocktwits
    Topics Intellectual Property
    News headline image
    Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Why Did QURE Stock Almost Halve Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction ↗
    Via Stocktwits
    News headline image
    IBRX Stock Rises Pre-Market After ANKTIVA Combo Shows Stronger Bladder Cancer Responses In Phase 2 Trial ↗
    Via Stocktwits
    News headline image
    CLDX Soars On Bullish Timelines For Urticaria Clinical Program: Retail Sees Experimental Skin Treatment’s Sales Beat Big Pharma’s Dupixent ↗
    Via Stocktwits
    Topics Earnings
    News headline image
    RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts ↗
    Via Stocktwits
    Topics Artificial Intelligence Earnings
    News headline image
    Why Did PVLA Stock Surge 45% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    RARE Stock Edges Up On Priority Review For Gene Therapy In Rare Metabolic Disorder ↗
    Via Stocktwits
    News headline image
    ImmunityBio Inks Partnerships To Launch Cancer Drug In Saudi Arabia Amid Expansion Efforts ↗
    Via Stocktwits

    Frequently Asked Questions

    Is State Street SPDR S&P Biotech ETF publicly traded?
    Yes, State Street SPDR S&P Biotech ETF is publicly traded.
    What exchange does State Street SPDR S&P Biotech ETF trade on?
    State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
    What is the ticker symbol for State Street SPDR S&P Biotech ETF?
    The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
    What is the current price of State Street SPDR S&P Biotech ETF?
    The current price of State Street SPDR S&P Biotech ETF is 132.50
    When was State Street SPDR S&P Biotech ETF last traded?
    The last trade of State Street SPDR S&P Biotech ETF was at 05/04/26 10:14 AM ET
    What is the market capitalization of State Street SPDR S&P Biotech ETF?
    The market capitalization of State Street SPDR S&P Biotech ETF is 71.75M
    How many shares of State Street SPDR S&P Biotech ETF are outstanding?
    State Street SPDR S&P Biotech ETF has 72M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.